Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab and Cabozantinib in Metastatic Pancreatic Cancer
NCT04820179Phase 2Completed
- Sponsor
- University of Arizona
- Start
- Oct 2021
- Primary completion
- Feb 2026
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab, cabozantinib in pancreatic cancer (PC), sponsored by University of Arizona. Started Oct 2021; status: completed.
02
Drugs
atezolizumabcabozantinib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04820179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04820179.